Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1788 1
1792 1
1794 3
1797 2
1800 2
1811 1
1812 1
1838 1
1840 1
1846 2
1847 1
1848 1
1856 1
1860 3
1861 2
1862 1
1863 1
1865 1
1869 1
1871 1
1873 1
1874 2
1876 1
1878 3
1879 1
1882 1
1883 3
1885 2
1886 1
1887 1
1888 2
1889 1
1890 1
1892 1
1893 1
1894 2
1895 2
1896 1
1897 9
1898 3
1899 1
1900 3
1908 1
1912 1
1913 1
1917 1
1918 1
1925 1
1926 12
1927 11
1928 6
1929 13
1930 8
1931 11
1932 15
1933 11
1934 20
1935 17
1936 7
1938 1
1940 1
1942 2
1943 1
1946 3
1947 3
1948 2
1950 4
1951 16
1952 15
1953 11
1954 10
1955 3
1956 8
1957 7
1958 4
1959 7
1960 5
1961 10
1962 3
1963 6
1964 12
1965 11
1966 5
1967 19
1968 7
1969 25
1970 22
1971 36
1972 23
1973 21
1974 24
1975 70
1976 52
1977 65
1978 52
1979 86
1980 97
1981 100
1982 127
1983 147
1984 134
1985 145
1986 170
1987 212
1988 247
1989 262
1990 305
1991 245
1992 1245
1993 1450
1994 1279
1995 986
1996 604
1997 421
1998 282
1999 320
2000 351
2001 333
2002 353
2003 281
2004 273
2005 252
2006 246
2007 254
2008 246
2009 239
2010 267
2011 241
2012 257
2013 370
2014 823
2015 943
2016 836
2017 804
2018 947
2019 1146
2020 1435
2021 1659
2022 1665
2023 1749
2024 622

Text availability

Article attribute

Article type

Publication date

Search Results

24,606 results

Results by year

Filters applied: . Clear all
The following term was not found in PubMed: Haghifam
Page 1
Surgical trends in breast cancer: a rise in novel operative treatment options over a 12 year analysis.
Jonczyk MM, Jean J, Graham R, Chatterjee A. Jonczyk MM, et al. Breast Cancer Res Treat. 2019 Jan;173(2):267-274. doi: 10.1007/s10549-018-5018-1. Epub 2018 Oct 25. Breast Cancer Res Treat. 2019. PMID: 30361873 Free PMC article. Review.
Few studies have analyzed national trends for the multitude of surgical options that include partial mastectomy (PM), mastectomy without reconstruction (M), mastectomy with reconstruction (M+R), and PM with oncoplastic reconstruction (OS). We hypothesize that the us …
Few studies have analyzed national trends for the multitude of surgical options that include partial mastectomy (PM), mastectomy without rec …
N.m.r. and biochemistry.
Campbell ID. Campbell ID. Biochem Soc Trans. 1991 Apr;19(2):243-8. doi: 10.1042/bst0190243. Biochem Soc Trans. 1991. PMID: 1889606 Review.
The role and historical progress of n.m.r. applications in biochemistry are briefly outlined. Technical advances over the years have made n.m.r., at last, a technique which can give valuable information about a wide range of biochemical topics, from en …
The role and historical progress of n.m.r. applications in biochemistry are briefly outlined. Technical advances over the year …
The cell as a realization of the (M, R) system.
Vega F. Vega F. Biosystems. 2023 Mar;225:104846. doi: 10.1016/j.biosystems.2023.104846. Epub 2023 Feb 10. Biosystems. 2023. PMID: 36775022 Free article.
Robert Rosen defines organisms as natural systems closed to efficient causation, and proposes the (M, R) system as a model for them. He argues that the study of this formal system provides an understanding of living beings that cannot be obtained from conventional b …
Robert Rosen defines organisms as natural systems closed to efficient causation, and proposes the (M, R) system as a model for …
Rosen's (M,R) system in Unified Modelling Language.
Zhang L, Williams RA, Gatherer D. Zhang L, et al. Biosystems. 2016 Jan;139:29-36. doi: 10.1016/j.biosystems.2015.12.006. Epub 2015 Dec 23. Biosystems. 2016. PMID: 26723228 Free article.
Robert Rosen's (M,R) system is an abstract biological network architecture that is allegedly non-computable on a Turing machine. If (M,R) is truly non-computable, there are serious implications for the modelling of large biological networks in computer …
Robert Rosen's (M,R) system is an abstract biological network architecture that is allegedly non-computable on a Turing machin …
Organizational invariance in (M,R)-systems.
Cornish-Bowden A, Cárdenas ML. Cornish-Bowden A, et al. Chem Biodivers. 2007 Oct;4(10):2396-406. doi: 10.1002/cbdv.200790195. Chem Biodivers. 2007. PMID: 17955465
Although it is not difficult to construct a model metabolic system to represent an (M,R)-system, such a model system will typically appear to lack organizational invariance, an essential property of a living (M,R)-system. To have this property, an ( …
Although it is not difficult to construct a model metabolic system to represent an (M,R)-system, such a model system will typi …
Theoretical Studies of Mutual Effects between 6-m-r Hemiketalization and 26-m-r Lactonization in Pimaricin Thioesterase.
Jiang C, Zhou Y, Tao W, Ji S, Mao Y, Shi T, Zheng J, Bai L, Zhao YL. Jiang C, et al. Chem Asian J. 2023 Apr 3;18(7):e202201229. doi: 10.1002/asia.202201229. Epub 2023 Feb 13. Chem Asian J. 2023. PMID: 36755200
As a thioesterase in type-I polyketide synthase, pimTE controls the 26-m-r macrolide main chain release in pimaricin biosynthesis. In this work, we sought to determine whether the 6-m-r hemiketal formation was linked to pimTE-catalyzed 26-m-r …
As a thioesterase in type-I polyketide synthase, pimTE controls the 26-m-r macrolide main chain release in pimaricin biosynthe …
Extremophilic Microfactories: Applications in Metal and Radionuclide Bioremediation.
Marques CR. Marques CR. Front Microbiol. 2018 Jun 1;9:1191. doi: 10.3389/fmicb.2018.01191. eCollection 2018. Front Microbiol. 2018. PMID: 29910794 Free PMC article. Review.
However, the natural physiological plasticity of such extremophilic microfactories can be further explored to nourish different hallmarks of M&R bioremediation, which are scantly approached in the literature and were never integrated. Therefore, this review not …
However, the natural physiological plasticity of such extremophilic microfactories can be further explored to nourish different hallmarks of …
Rosen's (M,R) system in process algebra.
Gatherer D, Galpin V. Gatherer D, et al. BMC Syst Biol. 2013 Nov 17;7:128. doi: 10.1186/1752-0509-7-128. BMC Syst Biol. 2013. PMID: 24237684 Free PMC article.
RESULTS: We instantiate (M,R) using the process algebra Bio-PEPA, and discuss the extent to which our model represents a true realization of (M,R). ...CONCLUSIONS: We argue that the behaviour of (M,R) in Bio-PEPA shows life-like propertie …
RESULTS: We instantiate (M,R) using the process algebra Bio-PEPA, and discuss the extent to which our model represents a true …
Rosen's (M,R) system as an X-machine.
Palmer ML, Williams RA, Gatherer D. Palmer ML, et al. J Theor Biol. 2016 Nov 7;408:97-104. doi: 10.1016/j.jtbi.2016.08.007. Epub 2016 Aug 9. J Theor Biol. 2016. PMID: 27519952
Robert Rosen's (M,R) system is an abstract biological network architecture that is allegedly both irreducible to sub-models of its component states and non-computable on a Turing machine. (M,R) stands as an obstacle to both reductionist and mechanistic …
Robert Rosen's (M,R) system is an abstract biological network architecture that is allegedly both irreducible to sub-models of …
M-M-R()II manufactured using recombinant human albumin (rHA) and M-M-R()II manufactured using human serum albumin (HSA) exhibit similar safety and immunogenicity profiles when administered as a 2-dose regimen to healthy children.
Wiedmann RT, Reisinger KS, Hartzel J, Malacaman E, Senders SD, Giacoletti KE, Shaw E, Kuter BJ, Schödel F, Musey LK. Wiedmann RT, et al. Vaccine. 2015 Apr 27;33(18):2132-40. doi: 10.1016/j.vaccine.2015.03.017. Epub 2015 Mar 18. Vaccine. 2015. PMID: 25796337
Antibody seroconversion rates to measles, mumps, and rubella were 97.0%, 99.5%, and 99.7%, respectively, for recipients of M-M-R()II with rHA and 97.2%, 97.9%, and 99.6%, respectively, for recipients of M-M-R()II with HSA, and geometric mean titers to …
Antibody seroconversion rates to measles, mumps, and rubella were 97.0%, 99.5%, and 99.7%, respectively, for recipients of M-M-R …
24,606 results
You have reached the last available page of results. Please see the User Guide for more information.